Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Isovue and Visipaque in Renally Impaired Patients Undergoing CT

NCT00292487 is registered in ClinicalTrials.gov with Bracco Diagnostics, Inc as lead sponsor.

NCT NCT00292487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00292487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Isovue and Visipaque in Renally Impaired Patients Undergoing CT
Lead sponsor
Bracco Diagnostics, Inc
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2004
Completion date
February 28, 2006
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast induced nephropathy